TMAO to the rescue of pathogenic protein variants

Biochim Biophys Acta Gen Subj. 2022 Nov;1866(11):130214. doi: 10.1016/j.bbagen.2022.130214. Epub 2022 Jul 25.

Abstract

Trimethylamine N-oxide (TMAO) is a chemical chaperone found in various organisms including humans. Various studies unveiled that it is an excellent protein-stabilizing agent, and induces folding of unstructured proteins. It is also well established that it can counteract the deleterious effects of urea, salt, and hydrostatic pressure on macromolecular integrity. There is also existence of large body of data regarding its ability to restore functional deficiency of various mutant proteins or pathogenic variants by correcting misfolding defects and inhibiting the formation of high-order toxic protein oligomers. Since an important class of human disease called "protein conformational disorders" is due to protein misfolding and/or formation of high-order oligomers, TMAO stands as a promising molecule for the therapeutic intervention of such diseases. The present review has been designed to gather a comprehensive knowledge of the TMAO's effect on the functional restoration of various mutants, identify its shortcomings and explore its potentiality as a lead molecule. Future prospects have also been suitably incorporated.

Keywords: Chemical chaperone; Functional rescue; Mutant protein; Protein conformational diseases; Proteopathies.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Methylamines*
  • Mutant Proteins
  • Proteins*
  • Urea

Substances

  • Methylamines
  • Mutant Proteins
  • Proteins
  • Urea
  • trimethyloxamine